LPA, the enzymatic product of ATX and its effector molecule, has been shown to directly affect HCV viral infection and replication [27,28], suggesting that a similar autocrine mode of action may be in play in COVID-19, where ATX produced by the infected host cell would stimulate local LPA production, in turn facilitating viral entry and replication. The gene discussed is ENPP2; the disease is COVID-19.